Alexion Pharmaceuticals, Inc. (ALXN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
121 SEAPORT BOULEVARD BOSTON, MA 02210 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 3/31/2021 MRQ | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,999 | 2,750 | 1,564 | 1,474 | 1,293 | 1,385 | |||
| Cash and cash equivalents | 2,965 | 2,686 | 1,366 | 584 | 966 | 1,010 | |||
| Short-term investments | 35 | 64 | 198 | 890 | 327 | 375 | |||
| Receivables | 1,409 | 1,243 | 922 | 727 | 650 | 533 | |||
| Inventory, net of allowances, customer advances and progress billings | 862 | 628 | 473 | 460 | 375 | 290 | |||
| Inventory | 862 | 628 | 473 | 460 | 375 | 290 | |||
| Other current assets | 649 | 456 | 426 | 293 | 260 | 218 | |||
| Other undisclosed current assets | (87) | ||||||||
| Total current assets: | 5,833 | 5,076 | 3,385 | 2,954 | 2,578 | 2,425 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 223 | ✕ | ✕ | ✕ | ✕ | ||||
| Property, plant and equipment | 1,239 | 1,163 | 1,472 | 1,325 | 1,036 | 697 | |||
| Intangible assets, net (including goodwill) | 8,103 | 8,382 | 8,679 | 8,992 | 9,340 | 9,756 | |||
| Goodwill | 5,100 | 5,037 | 5,037 | 5,037 | 5,037 | 5,048 | |||
| Intangible assets, net (excluding goodwill) | 3,002 | 3,344 | 3,641 | 3,954 | 4,303 | 4,708 | |||
| Restricted cash and investments | 0 | ||||||||
| Deferred income tax assets | 2,199 | ✕ | ✕ | ✕ | ✕ | ||||
| Other noncurrent assets | 506 | 429 | 397 | 312 | 299 | 255 | |||
| Other undisclosed noncurrent assets | 2,494 | ||||||||
| Total noncurrent assets: | 12,270 | 12,468 | 10,547 | 10,629 | 10,675 | 10,708 | |||
| TOTAL ASSETS: | 18,103 | 17,545 | 13,932 | 13,583 | 13,253 | 13,133 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 393 | 967 | 698 | 710 | 572 | 461 | |||
| Taxes payable | 151 | 104 | 24 | ||||||
| Employee-related liabilities | 242 | 191 | 170 | ||||||
| Accounts payable | 71 | 64 | 57 | ||||||
| Accrued liabilities | 201 | 171 | 639 | 508 | 403 | ||||
| Other undisclosed accounts payable and accrued liabilities | 471 | 332 | |||||||
| Debt | 142 | 127 | 94 | 167 | 167 | 175 | |||
| Restructuring reserve | 4 | ||||||||
| Business combination, contingent consideration, liability | 115 | 98 | 24 | ||||||
| Other liabilities | 164 | 101 | 34 | 59 | 23 | 62 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 16 | 37 | 21 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 3 | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 810 | 242 | |||||||
| Total current liabilities: | 1,625 | 1,194 | 1,174 | 953 | 823 | 718 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2,664 | 2,375 | 2,502 | 2,721 | 2,888 | 3,281 | |||
| Long-term debt, excluding current maturities | 2,420 | 2,375 | 2,502 | 2,721 | 2,888 | 3,281 | |||
| Finance lease, liability | 67 | ✕ | ✕ | ✕ | ✕ | ||||
| Liabilities, other than long-term debt | 1,931 | 293 | 173 | 159 | 110 | 626 | |||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | 529 | |||||
| Deferred income tax liabilities | 1,632 | ✕ | ✕ | ✕ | ✕ | ||||
| Liability, pension and other postretirement and postemployment benefits | 28 | 18 | 19 | 20 | 23 | ||||
| Other liabilities | 299 | 266 | 156 | 140 | 90 | 73 | |||
| Operating lease, liability | 177 | ✕ | ✕ | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 232 | 2,410 | 918 | 858 | 738 | 249 | |||
| Total noncurrent liabilities: | 4,827 | 5,079 | 3,593 | 3,738 | 3,736 | 4,156 | |||
| Total liabilities: | 6,452 | 6,273 | 4,767 | 4,690 | 4,559 | 4,875 | |||
| Equity | |||||||||
| Equity, attributable to parent | 11,651 | 11,272 | 9,165 | 8,893 | 8,694 | 8,259 | |||
| Common stock | 0 | ||||||||
| Treasury stock, value | (2,620) | (2,106) | (1,690) | (1,605) | (1,141) | (711) | |||
| Additional paid in capital | 9,153 | 8,805 | 8,539 | 8,290 | 7,957 | 7,727 | |||
| Accumulated other comprehensive income (loss) | (125) | (67) | (10) | (34) | 60 | 62 | |||
| Retained earnings | 5,243 | 4,640 | 2,326 | 2,242 | 1,818 | 1,180 | |||
| Total equity: | 11,651 | 11,272 | 9,165 | 8,893 | 8,694 | 8,259 | |||
| TOTAL LIABILITIES AND EQUITY: | 18,103 | 17,545 | 13,932 | 13,583 | 13,253 | 13,133 | |||
Income Statement (P&L) ($ in millions)
| 3/31/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,070 | 4,991 | 4,131 | 3,551 | 3,082 | 2,603 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 3,551 | 3,084 | 2,604 | |
| Cost of revenue | (600) | (395) | (374) | (454) | (258) | (233) | ||
| Cost of goods and services sold | (554) | (395) | (374) | (454) | (258) | (233) | ||
| Gross profit: | 5,470 | 4,597 | 3,757 | 3,097 | 2,824 | 2,369 | ||
| Operating expenses | (4,838) | (2,476) | (3,487) | (2,470) | (2,159) | (1,834) | ||
| Other undisclosed operating income | 2 | 2 | ||||||
| Operating income: | 632 | 2,120 | 270 | 627 | 667 | 537 | ||
| Nonoperating income | 41 | 136 | 71 | 19 | 6 | 9 | ||
| Investment income, nonoperating | 45 | 100 | 65 | 19 | 11 | 9 | ||
| Gain (loss), foreign currency transaction, before tax | 0 | (5) | 1 | |||||
| Other nonoperating income (expense) | (3) | 36 | 6 | |||||
| Interest and debt expense | (105) | (78) | (98) | (98) | (97) | (48) | ||
| Income from continuing operations before income taxes: | 569 | 2,179 | 242 | 548 | 576 | 498 | ||
| Income tax expense (benefit) | 34 | 226 | (165) | (105) | (177) | (354) | ||
| Income from continuing operations: | 603 | 2,404 | 78 | 443 | 399 | 144 | ||
| Income before gain (loss) on sale of properties: | ✕ | 603 | 2,404 | 78 | 443 | 399 | 144 | |
| Net income available to common stockholders, diluted: | 603 | 2,404 | 78 | 443 | 399 | 144 | ||
Comprehensive Income ($ in millions)
| 3/31/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 603 | 2,404 | 78 | 443 | 399 | 144 | ||
| Other comprehensive income (loss) | 19 | 10 | (7) | 2 | 3 | |||
| Comprehensive income: | 622 | 2,415 | 71 | 445 | 399 | 147 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (77) | (67) | 32 | (97) | (2) | 2 | ||
| Comprehensive income, net of tax, attributable to parent: | 546 | 2,347 | 102 | 348 | 397 | 150 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.